🇺🇸 FDA

Company profile · Sponsor

Chengdu

Chengdu University of Traditional Chinese Medicine

CEE7A43 · NMPA pharma CN
Pipeline
1
Drugs
0
Patents
0

Quick answer

Chengdu (CEE7A43) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker CEE7A43
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (1)

Search pipeline →

  1. Loperamide

    Chengdu

    Diarrhea-predominant Irritable Bowel Syndrome

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is Chengdu?

Chengdu (CEE7A43) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Chengdu sponsor?

We track 1 ClinicalTrials.gov-linked program for Chengdu, including Loperamide. Open each program for phase, modality, NCT IDs, and indication details.

Where does Chengdu company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.